Dependence-like behaviour in patients treated for medication overuse headache: A prospective open-label randomized controlled trial.
Journal
European journal of pain (London, England)
ISSN: 1532-2149
Titre abrégé: Eur J Pain
Pays: England
ID NLM: 9801774
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
28
08
2020
accepted:
12
12
2020
pubmed:
17
12
2020
medline:
28
4
2021
entrez:
16
12
2020
Statut:
ppublish
Résumé
Dependence-like behaviour may complicate withdrawal and increase risk of relapse of medication overuse headache (MOH). The most effective treatment for reducing dependence-like behaviour is unknown. To compare patient-reported outcomes among three treatment strategies for MOH. The primary outcome was change in Severity of Dependence Scale (SDS) score from baseline to 6 months. Patients with MOH were randomized to (1) withdrawal combined with preventive medication from start (W+P), (2) preventive medication without withdrawal (P), or (3) withdrawal with optional preventive medication 2 months after withdrawal (W). At baseline, 2, and 6 months, patients filled out SDS (used for measurements of dependence-like behaviour and treatment feasibility), Headache Under-Response of Treatment (HURT) and WHO Quality of Life BREF questionnaires. Out of 120 patients with MOH, 100 completed the 6-month follow-up and filled out questionnaires. The W+P arm was the most effective in treating MOH. After 6 months, the SDS score was reduced by 3.69 (95% CI 3.23-4.49) in the W+P arm, by 3.19 (95% CI 2.43-3.96) in the W arm, and by 1.65 (95% CI 0.96-2.33) in the P arm (p = 0.04). At baseline and after 2 months, the P arm was considered the most feasible treatment, but at 6-month follow-up, there was no difference in feasibility score, change in HURT score, or quality of life. Dependence-like behaviour was reduced most in the two withdrawal arms. Withdrawal combined with preventive medication is recommended for the treatment of MOH. Withdrawal combined with preventive medication from start is the treatment strategy that reduces dependence-like behaviour the most in MOH patients. Patients initially considered preventive treatment without withdrawal as the most feasible treatment. However, no difference in feasibility between the three arms was found at 6-month follow-up. Withdrawal combined with preventive medication is recommended for treatment of MOH.
Sections du résumé
BACKGROUND
Dependence-like behaviour may complicate withdrawal and increase risk of relapse of medication overuse headache (MOH). The most effective treatment for reducing dependence-like behaviour is unknown.
OBJECTIVES
To compare patient-reported outcomes among three treatment strategies for MOH. The primary outcome was change in Severity of Dependence Scale (SDS) score from baseline to 6 months.
METHODS
Patients with MOH were randomized to (1) withdrawal combined with preventive medication from start (W+P), (2) preventive medication without withdrawal (P), or (3) withdrawal with optional preventive medication 2 months after withdrawal (W). At baseline, 2, and 6 months, patients filled out SDS (used for measurements of dependence-like behaviour and treatment feasibility), Headache Under-Response of Treatment (HURT) and WHO Quality of Life BREF questionnaires.
RESULTS
Out of 120 patients with MOH, 100 completed the 6-month follow-up and filled out questionnaires. The W+P arm was the most effective in treating MOH. After 6 months, the SDS score was reduced by 3.69 (95% CI 3.23-4.49) in the W+P arm, by 3.19 (95% CI 2.43-3.96) in the W arm, and by 1.65 (95% CI 0.96-2.33) in the P arm (p = 0.04). At baseline and after 2 months, the P arm was considered the most feasible treatment, but at 6-month follow-up, there was no difference in feasibility score, change in HURT score, or quality of life.
CONCLUSIONS
Dependence-like behaviour was reduced most in the two withdrawal arms. Withdrawal combined with preventive medication is recommended for the treatment of MOH.
SIGNIFICANCE
Withdrawal combined with preventive medication from start is the treatment strategy that reduces dependence-like behaviour the most in MOH patients. Patients initially considered preventive treatment without withdrawal as the most feasible treatment. However, no difference in feasibility between the three arms was found at 6-month follow-up. Withdrawal combined with preventive medication is recommended for treatment of MOH.
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
852-861Informations de copyright
© 2020 European Pain Federation - EFIC®.
Références
Carlsen, L. N., Munksgaard, S. B., Nielsen, M., Engelstoft, I. M. S., Westergaard, M. L., Bendtsen, L., & Jensen, R. H. (2020). Comparison of 3 treatment strategies for medication overuse headache: A randomized clinical trial. JAMA Neurology, 77(9), 1-10. https://doi.org/10.1001/jamaneurol.2020.1179
Chiang, C. C., Schwedt, T. J., Wang, S. J., & Dodick, D. W. (2015). Treatment of medication-overuse headache: A systematic review. Cephalalgia, 36(4), 371-386. https://doi.org/10.1177/0333102415593088
Cupini, L. M., Costa, C., Sarchielli, P., Bari, M., Battista, N., Eusebi, P., Calabresi, P., & Maccarrone, M. (2008). Degradation of endocannabinoids in chronic migraine and medication overuse headache. Neurobiology of Disease, 30(2), 186-189. https://doi.org/10.1016/j.nbd.2008.01.003
Diener, H. C., Antonaci, F., Braschinsky, M., Evers, S., Jensen, R., Lainez, M., Kristoffersen, E. S., Tassorelli, C., Ryliskiene, K., & Petersen, J. A. (2020). European Academy of Neurology guideline on the management of medication-overuse headache. European Journal of Neurology, 27(7), 1102-1116. https://doi.org/10.1111/ene.14268
Diener, H. C., Dodick, D., Evers, S., Holle, D., Jensen, R. H., Lipton, R. B., Porreca, F., Silberstein, S., & Schwedt, T. (2019). Pathophysiology, prevention, and treatment of medication overuse headache. The Lancet Neurology, 18(9), 891-902. https://doi.org/10.1016/s1474-4422(19)30146-2
Engelstoft, I. M. S., Carlsen, L. N., Munksgaard, S. B., Nielsen, M., Jensen, R. H., & Bendtsen, L. (2019). Complete withdrawal is the most feasible treatment for medication-overuse headache: A randomized controlled open-label trial. European Journal of Pain (United Kingdom), 23, 1162-1170. https://doi.org/10.1002/ejp.1383
Evers, S., & Jensen, R. (2011). Treatment of medication overuse headache - guideline of the EFNS headache panel. European Journal of Neurology, 18(9), 1115-1121. https://doi.org/10.1111/j.1468-1331.2011.03497.x
Evers, S., & Marziniak, M. (2010). Clinical features, pathophysiology, and treatment of medication-overuse headache. The Lancet Neurology, 9(4), 391-401. https://doi.org/10.1016/S1474-4422(10)70008-9
Fenstermacher, N., Levin, M., & Ward, T. (2011). Pharmacological prevention of migraine. BMJ, 342(feb18 1), d583. https://doi.org/10.1136/bmj.d583
Fuh, J. L., Wang, S. J., Lu, S. R., & Juang, K. D. (2005). Does medication overuse headache represent a behavior of dependence? Pain, 119(1-3), 49-55. https://doi.org/10.1016/j.pain.2005.09.034
Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995). The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90(5), 607-614. https://doi.org/10.1046/j.1360-0443.1995.9056072.x
Grande, R. B., Aaseth, K., Šaltyte Benth, J., Gulbrandsen, P., Russell, M. B., & Lundqvist, C. (2009). The Severity of Dependence Scale detects people with medication overuse: The Akershus study of chronic headache. Journal of Neurology, Neurosurgery and Psychiatry, 80(7), 784-789. https://doi.org/10.1136/jnnp.2008.168864
IHS. (2014). The international Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia, 34(14), 1193-1199. https://doi.org/10.1177/0333102414534327
Jonsson, P., Jakobsson, A., Hensing, G., Linde, M., Moore, C. D., & Hedenrud, T. (2013). Holding on to the indispensable medication -A grounded theory on medication use from the perspective of persons with medication overuse headache. Journal of Headache and Pain, 14(1), 1. https://doi.org/10.1186/1129-2377-14-43
Krishnan, A., & Silver, N. (2016). Headache (chronic tension-type) Search date December 2013. Clinical Evidence, 1-22.
Lampl, C., Thomas, H., Tassorelli, C., Katsarava, Z., Laínez, J. M., Lantéri-Minet, M., Rastenyte, D., Ruiz de la Torre, E., Stovner, L. J., Andrée, C., & Steiner, T. J. (2016). Headache, depression and anxiety: Associations in the Eurolight project. Journal of Headache and Pain, 17(1), https://doi.org/10.1186/s10194-016-0649-2
Lantéri-Minet, M., Duru, G., Mudge, M., & Cottrell, S. (2011). Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: A systematic review. Cephalalgia, 31(7), 837-850. https://doi.org/10.1177/0333102411398400
Louter, M. A., Robbins, M. S., & Terwindt, G. M. (2017). Medication overuse headache: An ongoing debate. Neurology, 89(12), 1206-1207. https://doi.org/10.1212/WNL.0000000000004374
Lundqvist, C., Gossop, M., Russell, M. B., Straand, J., & Kristoffersen, E. S. (2019). Severity of analgesic dependence and medication-overuse headache. Journal of Addiction Medicine, 13(5), 346-353. https://doi.org/10.1097/adm.0000000000000504
Lundqvist, C., Grande, R. B., Aaseth, K., & Russell, M. B. (2012). Dependence scores predict prognosis of medication overuse headache: A prospective cohort from the Akershus study of chronic headache. Pain, 153(3), 682-686. https://doi.org/10.1016/j.pain.2011.12.008
Maldonado, R., Valverde, O., & Berrendero, F. (2006). Involvement of the endocannabinoid system in drug addiction. Trends in Neurosciences, 29(4), 225-232. https://doi.org/10.1016/j.tins.2006.01.008
Munksgaard, S. B., Madsen, S. K., & Wienecke, T. (2019). Treatment of medication overuse headache-A review. Acta Neurologica Scandinavica, 139(5), 405-414. https://doi.org/10.1111/ane.13074
Nielsen, M., Carlsen, L. N., Munksgaard, S. B., Engelstoft, I. M. S., Jensen, R. H., & Bendtsen, L. (2019). Complete withdrawal is the most effective approach to reduce disability in patients with medication-overuse headache: A randomized controlled open-label trial. Cephalalgia, 39(7), 863-872. https://doi.org/10.1177/0333102419828994
Olesen, J. (2012). Detoxification for medication overuse headache is the primary task. Cephalalgia, 32(5), 420-422. https://doi.org/10.1177/0333102411431309
Radat, F., Creach, C., Guegan-Massardier, E., Mick, G., Guy, N., Fabre, N., Giraud, P., Nachit-Ouinekh, F., & Lantri-Minet, M. (2008). Behavioral dependence in patients with medication overuse headache: A cross-sectional study in consulting patients using the DSM-IV criteria. Headache, 48(7), 1026-1036. https://doi.org/10.1111/j.1526-4610.2007.00999.x
Radat, F., & Lanteri-Minet, M. (2010). What is the role of dependence-related behavior in medication-overuse headache? Headache, 50(10), 1597-1611. https://doi.org/10.1111/j.1526-4610.2010.01755.x
Saper, J. R., & Lake, A. E. (2006). Medication overuse headache: Type I and type II [2]. Cephalalgia, 26(10), 1262. https://doi.org/10.1111/j.1468-2982.2006.01198.x
Skevington, S. M., Lotfy, M., & O’Connell, K. A. (2004). The World Health Organization’s WHOQOL-BREF Quality of Life Assessment: Psychometric Properties and Results of the International Field Trial A Report from the WHOQOL Group. Quality of Life Research, 13(2), 299-310. https://doi.org/10.1023/B:QURE.0000018486.91360.00
Steiner, T. J., Buse, D. C., Al Jumah, M., Westergaard, M. L., Jensen, R. H., Reed, M. L., Prilipko, L., Mennini, F. S., Láinez, M. J. A., Ravishankar, K., Sakai, F., Yu, S. Y., Fontebasso, M., Al Khathami, A., MacGregor, E. A., Antonaci, F., Tassorelli, C., & Lipton, R. B. (2018). The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: Development, psychometric evaluation and assessment of utility. Journal of Headache and Pain, 19(1), https://doi.org/10.1186/s10194-018-0842-6
Westergaard, M. L., Glümer, C., Hansen, E. H., & Jensen, R. H. (2014). Prevalence of chronic headache with and without medication overuse: Associations with socioeconomic position and physical and mental health status. Pain, 155(10), 2005-2013. https://doi.org/10.1016/j.pain.2014.07.002
Westergaard, M. L., Lau, C. J., Allesøe, K., Gjendal, S. T., & Jensen, R. H. (2019). Monitoring chronic headache and medication-overuse headache prevalence in Denmark. Cephalalgia, 40(1), 6-18. https://doi.org/10.1177/0333102419876909
Westergaard, M. L. S., Steiner, T. J., MacGregor, E. A., Antonaci, F., Tassorelli, C., Buse, D. C., Lipton, R. B., & Jensen, R. H. (2013). The Headache Under-Response to Treatment (HURT) questionnaire: Assessment of utility in headache specialist care. Cephalalgia, 33(4), 245-255. https://doi.org/10.1177/0333102412469740
WHO. (1996). The WHOQOL BREF Introduction, administration, scoring and generic version of the assessment. WHO.